Repligen
RGEN
#2040
Rank
C$13.01 B
Marketcap
C$231.15
Share price
-0.46%
Change (1 day)
10.17%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of September 2025 : C$2.90 Billion

According to Repligen 's latest financial reports the company has C$2.90 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$2.83 B8.62%
2023-12-31$C$2.60 B0.51%
2022-12-31$C$2.59 B16.25%
2021-12-31$C$2.23 B14.39%
2020-12-31$C$1.94 B40.87%
2019-12-31$C$1.38 B65.07%
2018-12-31$C$0.83 B12.75%
2017-12-31$C$0.74 B227.93%
2016-12-31$C$0.22 B33.19%
2015-12-31$C$0.17 B31.32%
2014-12-31$C$0.12 B17.25%
2013-12-31$C$0.11 B32.2%
2012-12-31$C$83.65 M
2011-03-31$C$65.05 M-2.42%
2010-03-31$C$66.66 M-23.33%
2009-03-31$C$86.95 M33.72%
2008-03-31$C$65.02 M119.96%
2007-03-31$C$29.56 M-1.21%
2006-03-31$C$29.92 M1.53%
2005-03-31$C$29.47 M-17%
2004-03-31$C$35.51 M-1.52%
2003-03-31$C$36.05 M-14.53%
2002-03-31$C$42.18 M-13.46%
2001-03-31$C$48.74 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novavax
NVAX
-C$0.22 Billion-107.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.44 B 190.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$4.18 B 44.19%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$26.52 B 813.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$71.33 B 2,355.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.93 B 792.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$129.82 B 4,369.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$2.74 B-5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$8.7 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$4.81 B 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA